+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Minimally Invasive Surgery Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805829
The global minimally invasive surgery market value was USD 43.5 billion in 2022, driven by the increasing technological advancements in surgical instruments and imaging systems across the globe. The market size is anticipated to grow at a CAGR of 6.7% during the forecast period of 2023-2031 to achieve a value of USD 77.8 billion by 2031.

Introduction

Minimally invasive surgery (MIS), also known as minimally invasive procedures or keyhole surgery, is a surgical technique that involves making small incisions in the body to perform surgical procedures with the assistance of specialized instruments and advanced imaging technologies. This approach aims to minimize trauma to the body, reduce post-operative pain, shorten recovery time, and enhance patient outcomes compared to traditional open surgery.

Key Trends in the Minimally Invasive Surgery Market

Some key trends involved in the minimally invasive surgery market are as follows:
  • Advancements in Surgical Instruments and Technologies: The field of minimally invasive surgery continues to witness advancements in surgical instruments, tools, and technologies. These innovations enable surgeons to perform complex procedures with greater precision and accuracy. Examples include robotic-assisted surgical systems, laparoscopic instruments with improved dexterity, and high-definition imaging systems
  • Increasing Adoption of Robotic Surgery: Robotic-assisted surgery has gained significant popularity in recent years. Robotic surgical systems provide surgeons with enhanced visualization, improved dexterity, and greater control during procedures. They enable complex and delicate surgeries to be performed with minimal invasiveness, leading to reduced complications and faster recovery times
  • Expansion of Indications: Initially, minimally invasive surgery was primarily used for simple procedures. However, advancements in technology and surgical techniques have expanded the scope of MIS to more complex surgeries across various medical specialties, including gynecology, urology, orthopedics, and cardiovascular surgery. This trend is driven by the growing evidence of the benefits of MIS, including reduced hospital stays, decreased post-operative pain, and faster return to normal activities
  • Growing Demand for Outpatient Procedures: Minimally invasive procedures are increasingly being performed in outpatient settings rather than traditional inpatient settings. This shift is driven by advancements in surgical techniques that allow for shorter hospital stays and faster recovery. Outpatient surgery centers offer convenience, cost savings, and reduced risk of hospital-acquired infections, contributing to the growing trend of performing MIS in ambulatory settings
  • Integration of Artificial Intelligence and Data Analytics: The integration of artificial intelligence (AI) and data analytics in minimally invasive surgery is gaining momentum. AI algorithms and machine learning techniques can analyze patient data, assist in surgical planning, and optimize surgical techniques. This integration has the potential to improve surgical outcomes, reduce complications, and personalize treatment strategies based on individual patient characteristics

Minimally Invasive Surgery Market Segmentations

Market Breakup by Product Type

  • Surgical Devices
  • Monitoring and Visualization Systems
  • Laparoscopy Devices
  • Endosurgical Equipment
  • Electrosurgical Equipment

Market Breakup by Technology

  • Transcatheter Surgery
  • Laparoscopy Surgery
  • Non-Visual Imaging
  • Medical Robotics

Market Breakup by Applications

  • Gastrointestinal Surgery
  • Gynecology Surgery
  • Urology Surgery
  • Cosmetic Surgery
  • Thoracic Surgery
  • Vascular Surgery
  • Orthopedic and Spine Surgery
  • Bariatric Surgery
  • Breast Surgery
  • Cardiac Surgery
  • Adrenalectomy Surgery
  • Anti-Reflux Surgery
  • Cancer Surgery
  • Cholecystectomy Surgery
  • Colectomy Surgery
  • Colon and Rectal Surgery
  • Ear, Nose and Throat Surgery
  • Obesity Surgery

Market Breakup by End User

  • Hospitals Surgical Department
  • Outpatient Surgery Patients
  • Individual Surgeons
  • Group Practice
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Minimally Invasive Surgery Market Scenario

The global minimally invasive surgery market has experienced significant growth in recent years and is expected to continue expanding in the coming years. Minimally invasive surgery offers several advantages over traditional open surgery, including reduced trauma, shorter hospital stays, faster recovery times, and improved patient outcomes. These benefits have driven the adoption of minimally invasive procedures across various medical specialties, such as cardiovascular, orthopedic, gastrointestinal, gynecological, and urological surgeries.

The market is primarily driven by factors such as technological advancements in surgical instruments and imaging systems, increasing prevalence of chronic diseases requiring surgical interventions, growing demand for minimally invasive procedures from patients, and the rising preference of healthcare providers for minimally invasive techniques. Furthermore, the shift toward value-based healthcare, cost containment efforts, and the need to reduce healthcare-associated infections have also contributed to the market growth.

Geographically, North America and Europe have been the dominant markets for minimally invasive surgery due to well-established healthcare infrastructure, high adoption rates, and favorable reimbursement policies. However, the Asia Pacific region is expected to witness rapid growth in the market due to the rising healthcare expenditure, increasing awareness about minimally invasive procedures, and growing healthcare infrastructure.

Overall, the global minimally invasive surgery market presents significant opportunities for market players, healthcare providers, and patients alike. With continued advancements in technology and increasing adoption of minimally invasive techniques, the market is poised for further growth and is likely to revolutionize surgical practices in the years to come.

Minimally Invasive Surgery Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Stryker
  • CONMED Corporation
  • Intuitive Surgical
  • NuVasive, Inc
  • Fortimedix Surgical
  • Microline Surgical
  • Cirtec
  • OmniGuide Holdings, Inc
  • Arthrex, Inc
  • Eximis Surgical, Inc
  • B. Braun Melsungen, AG
  • Medtronic
  • Johnson & Johnson Services, Inc
  • Abbott
  • Zimmer Biomet
  • Smith + Nephew

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Minimally Invasive Surgery Market Overview
3.1 Global Minimally Invasive Surgery Market Historical Value (2016-2022)
3.2 Global Minimally Invasive Surgery Market Forecast Value (2023-2031)
4 Global Minimally Invasive Surgery Market Landscape
4.1 Global Minimally Invasive Surgery Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Minimally Invasive Surgery Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Minimally Invasive Surgery Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Minimally Invasive Surgery Market Segmentation
6.1 Global Minimally Invasive Surgery Market by Product Type
6.1.1 Market Overview
6.1.2 Surgical Devices
6.1.3 Monitoring and Visualization Systems
6.1.4 Laparoscopy Devices
6.1.5 Endosurgical Equipment
6.1.6 Electrosurgical Equipment
6.2 Global Minimally Invasive Surgery Market by Technology
6.2.1 Market Overview
6.2.2 Transcatheter Surgery
6.2.3 Laparoscopy Surgery
6.2.4 Non-Visual Imaging
6.2.5 Medical Robotics
6.3 Global Minimally Invasive Surgery Market by Applications
6.3.1 Market Overview
6.3.2 Gastrointestinal Surgery
6.3.3 Gynecolog Surgery
6.3.4 Cosmetic Surgery
6.3.5 Thoracic Surgery
6.3.6 Vascular Surgery
6.3.7 Orthopedic and Spine Surgery
6.3.8 Bariatric Surgery
6.3.9 Breast Surgery
6.3.10 Cardiac Surgery
6.3.11 Others
6.4 Global Minimally Invasive Surgery Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Others
6.5 Global Minimally Invasive Surgery Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Minimally Invasive Surgery Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Minimally Invasive Surgery Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Minimally Invasive Surgery Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Minimally Invasive Surgery Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Minimally Invasive Surgery Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Stryker
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CONMED Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Intuitive Surgical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 NuVasive, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Fortimedix Surgical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Microline Surgical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cirtec
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 OmniGuide Holdings, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Arthrex, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Eximis Surgical, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 B. Braun Melsungen, AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Medtronic plc
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Johnson & Johnson
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Abbott Laboratories
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Zimmer Biomet
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Smith + Nephew
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Minimally Invasive Surgery Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Stryker
  • CONMED Corporation
  • Intuitive Surgical
  • NuVasive Inc.
  • Fortimedix Surgical
  • Microline Surgical
  • Cirtec
  • OmniGuide Holdings Inc.
  • Arthrex Inc.
  • Eximis Surgical Inc.
  • B. Braun Melsungen
  • AG
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Zimmer Biomet
  • Smith + Nephew

Methodology

Loading
LOADING...

Table Information